Optimizing antibiotic therapy of group IV community-acquired pneumonia patients
Journal Title: Медичні перспективи - Year 2014, Vol 19, Issue 2
Abstract
The aim of the study was to evaluate the clinical and economical effectiveness of differentiated antibacterial therapy of group IV patients with community-acquired pneumonia (CAP). Materials and methods. 42 patients, admitted to the hospital with severe CAP without risk factors for P. aeruginosa infection were randomized in three groups in 1:1:1 ratio. All patients received sequential antibacterial therapy with i.v. amoxicillin/clavulanate or ceftriaxone, or ertapenem in combination with azithromycin switched to oral amoxicillin/clavulanate, cefuroxime axetil in combination with oral azithromycin or levofloxacin, respectively, after initial improvement in 3–4 days. A comparative effectiveness analysis was performed based on clinical, laboratory and economic data. Results. Treatment outcomes in all subgroups of patients were similar: in 1st subgroup the cure rate was (28,6 12,1) %, improvement – in (49,4 13,2) % of patients; in 2nd and 3rd subgroups the cure/improvement rates were (35,7 12,8) and (42,9 13,2) %, respectively (р 0,05). Conclusion. Antibacterial therapy, always empiric and differentiated depending on severity of disease, con¬comitant conditions and previous use of antibiotics within 3 months of the onset of the disease, is a milestone of treatmet of CAP patients. A sequential antibiotic therapy with either aminopenicillin (amoxicillin/clavulanate) of 3rd generation cephalosporin (ceftriaxone/cefuroxime axetil) in combination with macrolide (azithromycin) or carbapenem (ertapenem, followed by levofloxacin) is recommended in hospitalized clinical group IV CAP patients without risk factors for P. aeruginosa infection. In current group of patients pharmacoeconomic analysis confirmed the expediency of administration a sequential antibiotic therapy with parenteral amoxicillin/clavulanat or ceftriaxone in combination with azithromycin, followed by oral amoxicillin/clavulanat or cefuroxime axetil in combination with azithromycin upon stabilization of patient’s condition.
Authors and Affiliations
Ya. Dziublyk
Keywords
Related Articles
- EP ID EP94308
- DOI -
- Views 136
- Downloads 0
Дніпропетровська гігієнічна школа: минуле, сьогодення, майбутне (до 90-річчя від заснування)
В статье представлен исторический анализ формирования гигиенической школы Днепропетровской медицинской академии за 100-летний период существования - от образования в XIX веке санитарного земства Катеринославской губернии...
Toxicological and hygienic regulation and assessment of danger of the new fungicide-cyflufenamid
Toxicodynamic peculiarities of the new fungicide – cyflufenamid were studied. It was found that in accordance with hygienic classification of pesticides, cyflufenamid is referred to the 3rd class of hazard (moderately...
Аналіз показників інвалідності внаслідок професійних захворювань у Львівській області: проблеми та перспективи вирішення
Анализ показателей инвалидности вследствие профессиональных заболеваний во Львовской области: проблемы и перспективы решения. Борисова И.С., Решота В.И., Николишин З.М. Инвалидность представляет собой социальный феномен,...
Неврологічні особливості новонароджених дітей, асоційовані з «раннім доношеним» народженням
Неврологические особенности новорожденных детей, ассоциированные с «ранним доношенным» рождением. Мавропуло Т.К. Новорожденные дети, родившиеся в сроке 37-38 недель беременнности, подвергаются более высокому риску заб...
Landscape changes in the environment due to military actions and their epidemic risks
The article considers the influence of the military-ecological and man-caused-anthropogenic factors on the environment state and natural processes. Epidemic risks and consequences resulted from landscapic changes of the...